ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Synovitis"

  • Abstract Number: 1046 • ACR Convergence 2023

    The Level of RF or Anti-CCP Antibody Affect Ultrasound Synovial Findings in Patients with Rheumatoid Arthritis?

    Tadashi Okano1, Kenji Mamoto1, Yutaro Yamada1, Shohei Anno2, Yuka Domae1, Shingo Washida1, Asami Yagami1, Yuko Yoshida1, Tatsuya Koike3 and Hiroaki Nakamura1, 1Osaka Metropolitan University, Osaka, Japan, 2Yodogawa Christian Hospital, Osaka, Japan, 3Search Institute for Bone and Arthritis Disease (SINBAD), Shirahama Foundation for Health and Welfare, Shirahama, Japan

    Background/Purpose: Positive for auto-antibodies such as rheumatoid factor (RF) and anti-citrullinated peptide antibodies (CCP) or having high autoantibody titers is associated with the progression of…
  • Abstract Number: 1051 • ACR Convergence 2023

    Validation of Handheld Ultrasound Devices for Point of Care Use in Rheumatology: Interim Analysis

    sibel aydin1, seyyid acikgoz2, Ummugulsum Oguz3, antonio Vieira4, patrick Leclerc4, Suharsh Shah4, Lihi Eder5 and Gurjit S Kaeley6, 1University of Ottawa - Ottawa, Ottawa, ON, Canada, 2University of Ottawa, Rheumatology, Ottawa, ON, Canada, 3University of Ottawa, Ottawa, ON, Canada, 4Novartis Pharmaceuticals Canada Inc., Montreal, QC, Canada, 5Women’s College Research Institute, Division of Rheumatology, University of Toronto, Toronto, ON, Canada, 6University of Florida College of Medicine – Jacksonville, Ponte Vedra Beach, FL

    Background/Purpose: Ultrasonography (US) has experienced a rapid evolution in rheumatology. Despite many advantages being shown repeatedly, several barriers persist and stand in the way of…
  • Abstract Number: 1342 • ACR Convergence 2023

    The Delivery of the Super-repressor IκBα by Exosomes Has the Potential to Alleviate Inflammation Associated with Rheumatoid Arthritis

    Ki-Jeong Park1, Ji-Hyoun Kang1, Hae-In Lee2, Yu Jeong Lee1, Moon-Ju Kim1, So-Hee Ahn3, Jae-Kwang Yoo3, Chulhee Choi3 and Tae-jong Kim4, 1Chonnam National University Hospital, Gwangju, South Korea, 2Chonnam National University, Gwangju, South Korea, 3ILIAS Biologics, Daejeon, South Korea, 4Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwang-Ju, South Korea

    Background/Purpose: Rheumatoid arthritis (RA) is a persistent inflammatory disease primarily affecting the diarthrodial joints. Nuclear factor-κB (NF-κB) is a family of inducible transcription factors responsible…
  • Abstract Number: 1594 • ACR Convergence 2023

    Oral Delivery of Δ9-Tetrahydrocannabinol Provides Symptom and Disease Modification in a Mouse Model of Knee Osteoarthritis

    Jason rockel1, Anca Maglaviceanu2, Helena Fetter Filippini3, Ewa Wasilewski4, Melissa M. Lewis-Bakker4, Sarah Gabrial1, Evgeny Rossomacha1, Johana Garcia1, Nizar Mahomed5, Timothy Leroux5, Hance Clarke6, Robert P. Bonin3, Lakshmi P. Kotra7 and Mohit Kapoor1, 1Division of Orthopaedics, Osteoarthritis Research Program, Schroeder Arthritis Institute, and Krembil Research Institute, University Health Network, Toronto, ON, Canada, 2Division of Orthopaedics, Osteoarthritis Research Program, Schroeder Arthritis Institute, and Krembil Research Institute, University Health Network; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada, 3Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada, 4Krembil Research Institute, and Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 5Division of Orthopaedics, Osteoarthritis Research Program, Schroeder Arthritis Institute, Krembil Research Institute, and Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 6Krembil Research Institute, and Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, ON, Canada, 7Krembil Research Institute, University Health Network; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Osteoarthritis (OA) results in joint pain, cartilage degeneration, and synovitis. Recent studies suggest that some OA patients are self-medicating with cannabis. Δ9-tetrahydrocannabinol (THC) is…
  • Abstract Number: 0554 • ACR Convergence 2022

    Loss of Synovial Tissue Macrophage Homeostasis Precedes Rheumatoid Arthritis Clinical Onset

    Megan Hanlon1, Mary Canavan2, conor Smith3, Achilleas Floudas4, Nuno Neto5, Qingxuan Song6, Phil Gallagher7, Ronan Mullan8, Conor Hurson9, Barry Moran5, Michael Monaghan5, Sunil Nagpal10, Douglas Veale11 and Ursula Fearon5, 1Molecular Rheumatology, Dublin, Ireland, 2Trinity College, Dublin, Ireland, 3bTrinity College Dublin, Dublin, Ireland, 4Molecular Rheumatology Trinity Biomedical Sciences Institute, Dublin, Ireland, 5Trinity College Dublin, Dublin, Ireland, 6Janssen Research and Development, LLC, Spring House, PA, 7St Vincent's University Hospital, Dublin, Ireland, 8Tallaght University Hospital, Dublin, Ireland, 9St Vincents University Hospital, Dublin, Ireland, 10Janssen Research, Collegeville, PA, 11St. Vincent's University Hospital, Blackrock, Dublin, Ireland

    Background/Purpose: Synovial-tissue macrophages significantly contribute to Rheumatoid Arthritis, yet the precise nature/function of macrophage subsets within the inflamed joint remains unexplored. Here we explore the…
  • Abstract Number: 0619 • ACR Convergence 2022

    Differences Between Patients in Remission with Active Rheumatoid Arthritis by Histological and Molecular Comparisons

    Selina Ohl1, Klaus Frommer2, Markus Rickert3, Stefan Rehart4, Ulf Müller-Ladner5 and Elena Neumann6, 1Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Bad Nauheim, Germany, 2Justus Liebig University Gießen, Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Bad Nauheim, Germany, 3Dept. of Orthopaedics and Orthopaedic Surgery, University Hospital Giessen and Marburg, Giessen, Germany, Gießen, Germany, 4Agaplesion Markus Hospital, Dpt of Orthopaedics and Trauma Surgery, Frankfurt, Germany, 5JLU Campus KK, Bad Nauheim, Germany, 6JLU Gießen, Campus Kerckhoff, Bad Nauheim, Germany

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disease, whose inflammatory processes in the synovium lead to the destruction of cartilage and bone. Although there…
  • Abstract Number: 0758 • ACR Convergence 2022

    Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE)-like Syndrome After Immune Checkpoint Inhibition: A CanRIO Study

    Azin Rouhi1, Shahin Jamal2, Marie Hudson3, Janet Pope4, Janet Roberts5, Alexandra Ladouceur3, Sara Hewitt6 and Carrie Ye1, 1University of Alberta, Edmonton, AB, Canada, 2University of British Columbia, Vancouver, BC, Canada, 3McGill University, Montréal, QC, Canada, 4University of Western Ontario, London, ON, Canada, 5Dalhousie University, Halifax, NS, Canada, 6Western University, London, ON, Canada

    Background/Purpose: Immune checkpoint inhibitors (ICI) have shown great promise in the treatment of different malignancies. The use of ICIs has been associated with toxicities that…
  • Abstract Number: 0776 • ACR Convergence 2022

    Expert Clinical Management of Immune-related Inflammatory Arthritis: Results from a Multicenter International Expert Survey

    Sebastian Bruera1, Maria Suarez-Almazor2 and mar Riveiro-Barciela3, 1Baylor College of Medicine, Houston, TX, 2MD Anderson Cancer Center, Houston, TX, 3Hospital Universitari Vall d'Hebron, Barcelona, Spain

    Background/Purpose: The management of inflammatory arthritis related to immune-related adverse events (irAEs) from immune checkpoint inhibitors (ICI) is challenging. Arthritis can become chronic and require…
  • Abstract Number: 0803 • ACR Convergence 2022

    Performance of Adenosine Deaminase Activity in Sinovial Fluid for the Early Diagnosis of Tuberculous Arthritis: A Meta Analysis

    Juan Carlos Cortés-Quiroz1, Javier Ena2, José Antonio Bernal3 and José Rosas4, 1Marina Baixa Hospital, Mutxamel, Spain, 2Department of Internal Medicine. Marina Baixa Hospital, Villajoyosa, Spain, 3Rheumatology Department. Marina Baixa Hospital, Alicante, Spain, 4Rheumatology Department, Hospital Marina Baixa, Villajoyosa, Spain

    Background/Purpose: Adenosine deaminase (ADA) activity has shown good performance in diagnosing pleural, peritoneal, and meningeal tuberculosis. This study aimed to evaluate the performance of measuring…
  • Abstract Number: 1232 • ACR Convergence 2022

    Reliability and Validity of Single Axial Slice vs. Multiple Slice Quantitative Measurement of the Volume of Effusion-Synovitis on 3T Knee MRI in Knees with Osteoarthritis

    Greg Gilles1, Arjun Vohra1, Chelsea Caruso1, Dagoberto Robles1, Mihra Taljanovic1, Jeffrey Duryea2, Erin Ashbeck1, Edward Bedrick3 and Kent Kwoh4, 1University of Arizona Arthritis Center, Tucson, AZ, 2Brigham and Women's Hospital, Boston, MA, 3Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, 4University of Arizona, Tucson, AZ

    Background/Purpose: Effusion-synovitis (ES) on knee MRI has been identified as an important biomarker of OA. Semi-automated software methods offer objective measurements of ES volume on…
  • Abstract Number: 1389 • ACR Convergence 2022

    The New Serum Synovial Biochemical Marker HELIX-III Predicts Radiological Progression in Early Arthritis Independently of Usual Risk Factors

    Patrick Garnero1, Evelyne Gineyts1, Jean-Charles Rousseau1, Pascal Richette2, Jérémie SELLAM3 and Roland Chapurlat1, 1INSERM 1033, Lyon, France, 2Department of Rheumatology, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France, 3Sorbonne Universite, AP-HP, Saint-Antoine hospital, Paris, France

    Background/Purpose: The prognosis of rheumatoid arthritis (RA) is highly variable across patients (P.) and difficult to predict. Usual risk factors, e.g., radiological joint damage, increased…
  • Abstract Number: 1680 • ACR Convergence 2022

    Module Signatures of Synovial Single-cell States Identify Disease Phenotypes in Early Treatment-naive Rheumatoid Arthritis

    Felice Rivellese1, Elena Pontarini2, Cankut Cubuk1, Alessandra Nerviani1, Liliane Fossati-Jimack1, Anna Surace1, Elisabetta Sciacca3, Katriona Goldmann1, Michele Bombardieri4, Myles Lewis1 and Costantino Pitzalis1, 1Queen Mary University of London, London, United Kingdom, 2William Harvey Research Institute, London, United Kingdom, 3Queen Mary University of London, Biancavilla, Italy, 4Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University, London, United Kingdom

    Background/Purpose: Despite extensive studies, the relationship between circulating and local immune cells and clinico-pathological features of Immune-Mediated Inflammatory Diseases remains unclear. Recently, synovium-specific cell states…
  • Abstract Number: 1733 • ACR Convergence 2022

    Granzyme K Elicits a New Pathway for Complement Activation in RA Synovium

    Anna Jonsson1, Carlos Donado2, Emma Gomez-Rivas1 and Michael Brenner3, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: T cells are major drivers of rheumatoid arthritis (RA) pathogenesis. Most research has focused on CD4 T cells, but we have found that CD8+…
  • Abstract Number: 1833 • ACR Convergence 2022

    Intraarticular Morphine in Knee-arthritis – Results of a Randomized Placebo-controlled Trial

    Hildrun Haibel1, Joachim Sieper1, Denis Poddubnyy2, valeria Rios-Rodriguez3, Fabian Proft2, Mikhail Protopopov4, Judith Rademacher4, Sabrina Igel5, Peter Martus6 and Christoph Stein5, 1Charité - Universitätsmedizin, Berlin, Berlin, Germany, 2Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité – Universitätsmedizin Berlin, Berlin, Germany, 3Charité-Universitätsmedizin Berlin, Berlin, Germany, 4Charité Universitätsmedizin Berlin, Berlin, Germany, 5Charité University Medicine Berlin, Berlin, Germany, 6University Hospital Tübingen, Tübingen, Germany

    Background/Purpose: The current standard of intraarticular therapy in patients with inflammatory arthritis (e.g. rheumatoid arthritis; RA) or inflammatory exacerbations of osteoarthritis (OA) is the injection…
  • Abstract Number: 1906 • ACR Convergence 2022

    Bile Acid Profile Is Associated to Synovitis in Knee Osteoarthritis

    Roxana Coras1, Jessica Murillo Saich2, Michal Hose Sanchez3, Anne Quan3, Emily Gentry1, Pieter Dorrestein1, Nancy Lane4 and Monica Guma5, 1University of California San Diego, San Diego, CA, 2University of California San Diego, La Jolla, CA, 3VA San Diego Healthcare System, San Diego, CA, 4University of California Davis, Hillsborough, CA, 5Division of Rheumatology, Allergy, and Immunology, Department of Medicine, University of California San Diego, La Jolla, CA

    Background/Purpose: Increasing evidence indicates that low grade systemic and local inflammation contributes to osteoarthritis (OA) progression. Bioactive lipid mediators are signaling molecules involved in inflammatory…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology